Domů › Chronická lymfocytární leukemie › North Carolina › Durham
Klinické studie Chronická lymfocytární leukemie v Durham, NC
27 studií pro Chronická lymfocytární leukemie hledá účastníky v lokalitách v Durham a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Probíhá náborFáze 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Durham VA Medical Center, Durham
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Probíhá náborFáze 3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
- University of North Carolina-Hillsborough Campus, Hillsborough · Vzdálenost 13 mi
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Probíhá náborFáze 3
- University of North Carolina At Chapel Hill, Chapel Hill · Vzdálenost 10 mi
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Probíhá náborFáze 3
- Duke University Medical Center, Durham
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Probíhá náborFáze 3
- Duke University Medical Center, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · Vzdálenost 10 mi
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Probíhá náborFáze 3
- Duke University, Durham
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Probíhá náborFáze 2
- Duke University, Durham
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia
Probíhá náborFáze 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Probíhá náborFáze 1/2
- UNC School of Medicine, Division of Hematology, Chapel Hill · Vzdálenost 10 mi
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Probíhá náborFáze 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · Vzdálenost 10 mi
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
Probíhá náborFáze 2
- Research Site, Durham
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Probíhá náborFáze 1
- University of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Probíhá náborFáze 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Probíhá nábor
- North Carolina Basnight Cancer Hospital, Chapel Hill · Vzdálenost 10 mi
Registry of Older Patients With Cancer
Probíhá náborObservační studie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Vzdálenost 10 mi
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Probíhá náborFáze 1
- University of North Carolina, Chapel Hill · Vzdálenost 10 mi
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Probíhá náborFáze 4
- Duke University Medical Center, Durham
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Probíhá náborFáze 4
- Duke University Medical Center, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
Probíhá náborFáze 1
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Probíhá náborFáze 2
- University of North Carolina /ID# 233313, Chapel Hill · Vzdálenost 10 mi
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
Probíhá náborFáze 2
- The University of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Probíhá náborFáze 1
- Duke University, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Probíhá náborObservační studie
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · Vzdálenost 10 mi
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Probíhá náborFáze 2
- Durham VA Medical Center, Durham, NC, Durham
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Probíhá náborFáze 1
- University of North Carolina, Chapel Hill · Vzdálenost 10 mi
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Probíhá náborFáze 1
- Duke University, Durham
Studie Chronická lymfocytární leukemie v jiných městech
- Boston, MA31 studií
- Columbus, OH28 studií
- Washington, DC22 studií
- Seattle, WA20 studií
- Rochester, MN19 studií
- New York City, NY18 studií
- Houston, TX17 studií
- Baldwin Park, CA16 studií
- Milwaukee, WI15 studií
- Cincinnati, OH14 studií
- Chicago, IL14 studií
- Nashville, TN13 studií
Další studie v Durham
- Rakovina prsu63 studií
- Rakovina (všechny typy)58 studií
- Nemalobuněčný plicní karcinom39 studií
- Mnohočetný myelom37 studií
- Metastatický karcinom33 studií
- Akutní myeloidní leukemie33 studií
- Rakovina plic32 studií
- Rakovina prostaty32 studií
- Kolorektální karcinom28 studií
- Rakovina vaječníků27 studií
- Srdeční selhání26 studií
- Rakovina slinivky břišní24 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.